Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.
Although treatment of multiple sclerosis (MS) with the type I interferon (IFN) IFN-β lowers disease activity, the role of endogenous type I IFN in MS remains controversial. We studied CD4+ T cells and CD4+ T cell subsets, monocytes and dendritic cells by flow cytometry and analysed the relationship...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/6a9834ea9d174e548aeecffd4c7d52f9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!